Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Active Biotech AB ( (SE:ACTI) ) has shared an update.
Active Biotech AB has announced an Extraordinary General Meeting to discuss significant changes, including amendments to the Articles of Association and a new share issue. The proposed changes aim to increase the company’s share capital and authorize the Board to issue new shares, potentially impacting the company’s financial structure and attracting new investors.
More about Active Biotech AB
Active Biotech AB is a biotechnology company based in Lund, Sweden, focusing on the development of pharmaceuticals for the treatment of autoimmune diseases and cancer.
YTD Price Performance: 44.44%
Average Trading Volume: 4,892,505
Technical Sentiment Signal: Sell
Current Market Cap: SEK192.6M
See more data about ACTI stock on TipRanks’ Stock Analysis page.